Next, we wanted to assess the clinical relevance of these findings so as to determine the status of TMEM106B expression in human lung adenocarcinoma data sets and whether its expression profile could be associated as a prognostic indicator of disease outcome. The gene discussed is TMEM106B; the disease is lung adenocarcinoma.